TB-500 (Thymosin Beta-4) Dosage Chart
TB-500 is a synthetic version of the active region of Thymosin Beta-4, an actin-binding peptide studied for cell migration, angiogenesis, and wound, tendon, and muscle repair. Research protocols run a loading phase then a lower maintenance phase, and it is most often paired with BPC-157 for recovery work. Nearly all efficacy data is preclinical.
Half-life
Short plasma presence; sustained tissue activity (dosed 1-2x weekly)
Format
Injectable
Purity
≥98%
Protocols
3 variants
Research Protocols
Dosage Protocols
Each row reflects a common research protocol variant. These are reference ranges derived from published literature and community research — not medical guidance.
Protocol 1
Loading Protocol
Dose
2-2.5mg subcutaneous, twice weekly
Duration
4-6 weeks
The initial loading phase most research protocols use to reach tissue saturation. Split across two weekly injections. Injected subcutaneously, often near the area of interest for localized research.
Protocol 2
Maintenance Protocol
Dose
2-2.5mg subcutaneous, once weekly (or every other week)
Duration
Ongoing, as studied
After the loading block, the frequency drops. TB-500's sustained tissue activity is why weekly or biweekly dosing is used rather than daily.
Protocol 3
Recovery Stack (with BPC-157)
Dose
TB-500 (above) + BPC-157 250-500mcg daily
Duration
Matched to the TB-500 block
The classic 'Wolverine' recovery pairing. TB-500 drives cell migration systemically while BPC-157 acts locally on angiogenesis and gut/tendon repair. See the BPC-157 chart for its dosing.
Mixing Math
Reconstitution
Reference values for preparing a research vial. Adjust the syringe reading if you change the water volume.
Vial size
10mg vial
BAC water
2ml bacteriostatic water
Concentration
5mg/ml
Dose / ml
2.5mg = 0.5ml
Syringe units
50 IU per 2.5mg on a U-100 syringe
Frequently Paired
Common Stacks
Storage
Handling Notes
Lyophilized: -20°C long-term, 2-8°C short-term. Reconstituted with bacteriostatic water: refrigerate at 2-8°C and use within about 21-28 days. Swirl gently, never shake, and do not freeze the reconstituted solution.
Research Considerations
Cautions
- Nearly all TB-500 healing evidence is preclinical (animal and cell studies); human efficacy is not established.
- The same pro-angiogenic action that aids repair is a theoretical concern in anyone with an active or recent malignancy.
- TB-500 is prohibited in sport under WADA (S2). Tested athletes must avoid it entirely; there is no therapeutic-use exemption route for a non-approved compound.
- TB-500 is a research compound, not an approved therapy. Source only COA-verified material, since grey-market purity varies sharply.
Ready to start your research
Get TB-500 (Thymosin Beta-4) from Ascension Peptides
COA-verified, US-based, discreet shipping. Use code ENHANCED for 50% off your entire order.
Buy TB-500 (Thymosin Beta-4) nowResearch use only. Not medical advice. Browse all dosage charts